These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2230877)

  • 1. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33.
    Welt S; Divgi CR; Real FX; Yeh SD; Garin-Chesa P; Finstad CL; Sakamoto J; Cohen A; Sigurdson ER; Kemeny N
    J Clin Oncol; 1990 Nov; 8(11):1894-906. PubMed ID: 2230877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
    Welt S; Divgi CR; Scott AM; Garin-Chesa P; Finn RD; Graham M; Carswell EA; Cohen A; Larson SM; Old LJ
    J Clin Oncol; 1994 Jun; 12(6):1193-203. PubMed ID: 8201382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.
    Welt S; Divgi CR; Kemeny N; Finn RD; Scott AM; Graham M; Germain JS; Richards EC; Larson SM; Oettgen HF
    J Clin Oncol; 1994 Aug; 12(8):1561-71. PubMed ID: 8040668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
    Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
    Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.
    Welt S; Scott AM; Divgi CR; Kemeny NE; Finn RD; Daghighian F; Germain JS; Richards EC; Larson SM; Old LJ
    J Clin Oncol; 1996 Jun; 14(6):1787-97. PubMed ID: 8656247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.
    Oosterwijk E; Bander NH; Divgi CR; Welt S; Wakka JC; Finn RD; Carswell EA; Larson SM; Warnaar SO; Fleuren GJ
    J Clin Oncol; 1993 Apr; 11(4):738-50. PubMed ID: 8478666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.
    Scott AM; Lee FT; Jones R; Hopkins W; MacGregor D; Cebon JS; Hannah A; Chong G; U P; Papenfuss A; Rigopoulos A; Sturrock S; Murphy R; Wirth V; Murone C; Smyth FE; Knight S; Welt S; Ritter G; Richards E; Nice EC; Burgess AW; Old LJ
    Clin Cancer Res; 2005 Jul; 11(13):4810-7. PubMed ID: 16000578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
    Larson SM; Carrasquillo JA; Krohn KA; Brown JP; McGuffin RW; Ferens JM; Graham MM; Hill LD; Beaumier PL; Hellström KE
    J Clin Invest; 1983 Dec; 72(6):2101-14. PubMed ID: 6196380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of locally recurrent colorectal cancer with radiolabeled monoclonal antibody H-15.
    Sakamoto J; Kato T; Watanabe T; Murayama H; Wada K; Sato T; Takagi H; Kondo K; Sasaki F; Kido C
    Jpn J Cancer Res; 1992 Dec; 83(12):1373-81. PubMed ID: 1483951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
    Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
    Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
    Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
    Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
    Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.
    Scheinberg DA; Straus DJ; Yeh SD; Divgi C; Garin-Chesa P; Graham M; Pentlow K; Coit D; Oettgen HF; Old LJ
    J Clin Oncol; 1990 May; 8(5):792-803. PubMed ID: 2332769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Localization of radiolabeled antibody to carcinoembryonic antigen in patients with gastrointestinal carcinoma].
    Ohashi A
    Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):297-306. PubMed ID: 3713682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of radioiodinated monoclonal antibody in colorectal cancer. Initial dosimetry results.
    Cohn KH; Welt S; Banner WP; Harrington M; Yeh S; Sakamoto J; Cardon-Cardo C; Daly J; Kemeny N; Cohen A
    Arch Surg; 1987 Dec; 122(12):1425-9. PubMed ID: 3689120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of iodine-125 CC49 monoclonal antibody in patients with colon cancer.
    Cook CH; Hinkle GH; Thurston MO; Martin EW
    Cancer Biother Radiopharm; 1996 Dec; 11(6):415-22. PubMed ID: 10851502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.